Race Against Time of Validation Study of Trisomy 21 Diagnostic Test I

Scientists at GATC Biotech AG and LifeCodexx AG have just begun the clinical validation study of a non-invasive, prenatal diagnostic test based on next generation sequencing with IlluminaHiSeq 2000 technology. The test detects fetal trisomy 21 and is based on the sequencing cell-free fetal DNA from maternal blood.

At least 500 samples are required for the study and the launch of the prenatal diagnostic test onto the market is planned at the end of 2011. It keeps exciting what Sequenom and Verinata are doing in the meanwhile…

Carola Grimminger

About Carola Grimminger

New media trend scouting from a Marketing perspective. This is what Carola Grimminger stands for.

No comments yet... Be the first to leave a reply!